Masimo Corp. (MASI) Tops Q4 EPS by 4c

Masimo Corp. (NASDAQ: MASI) reported Q4 EPS of $0.91, $0.04 better than the analyst estimate of $0.87. Revenue for the quarter came in at $247.5 million versus the consensus estimate of $243.79 million.

Joe Kiani, Chairman and Chief Executive Officer of Masimo, said, “In 2019, we advanced our mission to improve patient outcomes while reducing the cost of care. To mark our 30th anniversary, we delivered a new product to care providers in every month of 2019, while we also grew our product revenue 12.8%, or 13.6% on a constant currency basis. We once again delivered above market growth and improved our non-GAAP operating margins by 200 basis points through disciplined execution of our strategy. For 2020, we are projecting product revenues of $1.035 billion, GAAP earnings per share of $3.64 and non-GAAP earnings per share of $3.56.”

For earnings history and earnings-related data on Masimo Corp. (MASI) click here.

You May Also Be Interested In

• Tesla touts acceleration of new models, but Q1 results fall short of estimates
• Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
• IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance